Richard Stewart
2020
In 2020, Richard Stewart earned a total compensation of $1M as Executive Chairman and Former Chief Executive Officer at OncoGenex Pharmaceuticals, a 30% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $225,630 |
---|---|
Option Awards | $333,029 |
Salary | $473,846 |
Total | $1,032,505 |
Stewart received $473.8K in salary, accounting for 46% of the total pay in 2020.
Stewart also received $225.6K in non-equity incentive plan and $333K in option awards.
Rankings
In 2020, Richard Stewart's compensation ranked 8,495th out of 13,090 executives tracked by ExecPay. In other words, Stewart earned more than 35.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,495 | 35th |
Manufacturing | 3,614 | 36th |
Chemicals And Allied Products | 1,461 | 35th |
Drugs | 1,272 | 35th |
In Vitro and In Vivo Diagnostic Substances | 31 | 48th |
Stewart's colleagues
We found two more compensation records of executives who worked with Richard Stewart at OncoGenex Pharmaceuticals in 2020.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019